QuidelOrtho Corporation (QDEL)

NASDAQ: QDEL · USD

$14.0

+0.40 (+3.0%)· Recorded snapshot

Market cap	959.7M
Revenue (ttm)	2.7B
Net income (ttm)	-1B
EPS (ttm)	-$15.4
Shares out	68.6M
P/E (forward)	12.7x
Volume	1,333,239
Beta	0.78

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.7B
Net income (ttm): -1B
EPS (ttm): -$15.4
P/E (forward): 12.7x
Market cap: 959.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E12.7

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-45.9

P25 -113.8P50 -46.5P75 -0.9

ROIC0.8

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All QDEL indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001906324
Company name	QuidelOrtho Corporation
Country	United States
Country code	US
CUSIP number	219798105
Earnings date	2026-11-03
Earnings time	amc
Employees	6,500
Employees change	-100
Employees growth	-1.52%
Enterprise value	$3.9B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-28
First seen	2026-05-09
Fiscal year end	December
Founded	1979
In index	RUSSELL2000
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US2197981051
Last 10-K release date	2026-02-19
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$959.7M
Market cap category	Small-Cap
Next earnings date	2026-11-03
Options	Yes
Price	$14.00
Price currency	USD
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	QDEL
U.S. state	California
Website	https://www.quidelortho.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	10.37x
Earnings yield	-110%
EV/EBIT	105.34x
EV/EBITDA	8.06x
EV/Sales	1.46x
FCF / EV yield	-5.4%
FCF yield	-22.09%
Forward EV/Sales	1.53x
Forward P/E	12.72x
Forward P/S	0.37x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	0.52x
P/S ratio	0.36x
Price/EBITDA ratio	1.97x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	1.39%
EBITDA margin	18.12%
Gross margin	44.86%
Operating margin	1.39%
Pretax margin	-38.52%
Profit margin	-39.2%
Profit per employee	$-161,292
Revenue per employee	$411,415
ROA	0.38%
ROA (5Y)	8.23%
ROCE	0.79%
ROE	-45.91%
ROE (5Y)	-7.71%
ROIC	0.8%
ROIC (5Y)	17.82%
SBC / revenue	1.65%
Tax / revenue	0.69%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	1
Gross profit growth	-7.55%
Gross profit growth (Q)	-0.33%
Gross profit growth 3Y	-9.18%
Gross profit growth 5Y	-4.33%
Net income growth quarters	1
Net income growth years	1
Operating income growth	-68.04%
Operating income growth 3Y	-52.03%
Operating income growth 5Y	-49.91%
Revenue growth	-2.46%
Revenue growth (Q)	2.77%
Revenue growth (QoQ)	1.79%
Revenue growth 10Y	30.51%
Revenue growth 3Y	-5.43%
Revenue growth 5Y	7.8%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-154M
Depreciation and amortization	$447.5M
EBIT	$37.1M
EBITDA	$484.6M
EPS	$-15.40
FCF per share	$-3.08
Financing cash flow	$273.1M
Free cash flow	$-211.2M
Free cash flow minus SBC	$-255.4M
Gross profit	$1.2B
Income taxes	$18.4M
Investing cash flow	$-244.8M
Net borrowing	$271.2M
Net cash flow	$-28.3M
Net income	$-1B
Operating cash flow minus SBC	$-101.4M
Operating income	$37.1M
Revenue	$2.7B
Stock-based compensation	$44.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.52
Book value per share	$25.99
Debt / EBITDA	5.82
Debt / equity	1.73
Interest coverage	0.18
Long-term assets	$4.3B
Long-term liabilities	$2.9B
Net cash (debt)	$-3B
Net cash / market cap	-308.82%
Net debt / EBITDA	6.09
Net debt / equity	1.66
Piotroski F-Score	4
Property, plant and equipment	$1.5B
Shareholders' equity	$1.8B
Tangible book value	$-903.5M
Tangible book value per share	$-13.23
Total assets	$5.7B
Total cash	$123.4M
Total debt	$3.1B
Total liabilities	$3.9B
WACC	6.03%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.44
Current assets	$1.4B
Current liabilities	$993.4M
Current ratio	1.39
Inventory turnover	2.46
Net working capital	$647.3M
Quick ratio	0.6
Working capital	$383.2M
Working capital turnover	10.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.89%
Dividend yield	0%
Shareholder yield	-0.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-32.62%
10Y return CAGR	-3.87%
10Y total return	-32.62%
150-day SMA	$13.88
15Y price change	-25.68%
15Y return CAGR	-1.96%
15Y total return	-25.68%
1D price change	2.98%
1M price change	27.93%
1M total return	27.93%
1W price change	-0.6%
1W total return	-0.6%
1Y price change	-52.53%
1Y return CAGR	-52.55%
1Y total return	-52.53%
20-day SMA	$13.08
200-day SMA	$16.46
20Y price change	-10.52%
20Y return CAGR	-0.55%
20Y total return	-10.52%
3M price change	-16.84%
3M total return	-16.84%
3Y price change	-77.05%
3Y return CAGR	-38.77%
3Y total return	-77.05%
50-day SMA	$12.79
50-day SMA vs 200-day SMA	50under200
52-week high	$35.58
52-week high date	2026-01-16
52-week low	$9.92
52-week low date	2026-05-11
5Y price change	-89.42%
5Y return CAGR	-36.19%
5Y total return	-89.42%
6M price change	13.87%
6M total return	13.87%
All-time high	$306.72
All-time high date	2020-08-06
All-time low	$1.63
All-time low date	1987-12-28
Average true range (ATR)	$1.02
Average volume	2.4M
Beta (1Y)	0.96
Beta (2Y)	1.28
Beta (5Y)	0.78
Change from 52-week high	-60.66%
Change from 52-week low	41.08%
Change from all-time high	-95.44%
Change from all-time low	761.23%
Change from open	0.76%
Day's gap	2.21%
Dollar volume	$18.7M
High price	$14.50
Low price	$13.80
Monthly RSI	35.24
Open price	$13.89
Position in 52-week range	27.86%
Premarket change	-0.07%
Premarket close	$13.59
Premarket price	$13.58
Previous close	$13.59
Price vs 150-day SMA	0.86%
Price vs 20-day SMA	6.97%
Price vs 200-day SMA	-14.98%
Price vs 50-day SMA	9.42%
Relative volume	0.57
RSI	58.51
Sharpe ratio	-0.4
Sharpe ratio (3Y)	-0.41
Sharpe ratio (5Y)	-0.45
Sortino ratio	-0.49
Sortino ratio (3Y)	-0.51
Sortino ratio (5Y)	-0.55
Volume	1.3M
Weekly RSI	47.54
YTD price change	-51%
YTD total return	-51%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	61.2M
Float percentage	89.18%
Shares change (QoQ)	0.15%
Shares change (YoY)	0.89%
Shares held by insiders	1.14%
Shares held by institutions	106.82%
Shares outstanding	68.6M
Short % of float	24.45%
Short % of shares	21.81%
Short ratio	11.1 days

Deeper analysis on QDEL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this QDEL report

Is a complete QDEL research report available?

No complete published report is available for QuidelOrtho Corporation (QDEL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

QuidelOrtho Corporation (QDEL)

Price

Financial snapshot

Fair-value bridge

Latest news · QDEL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All QDEL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on QDEL

Frequently asked questions